Compare · DD vs MBII
DD vs MBII
Side-by-side comparison of DuPont de Nemours Inc. (DD) and Marrone Bio Innovations Inc. (MBII): market cap, price performance, sector, and recent activity on the wire.
Summary
- DD operates in Industrials, while MBII operates in Basic Industries - the two are in different parts of the market.
- DD is the larger of the two at $19.20B, about 202.2x MBII ($95.0M).
- DD has hit the wire 18 times in the past 4 weeks while MBII has been quiet.
- DD has more recent analyst coverage (25 ratings vs 2 for MBII).
- Company
- DuPont de Nemours Inc.
- Marrone Bio Innovations Inc.
- Price
- $46.84-1.71%
- $0.80-19.86%
- Market cap
- $19.20B
- $95.0M
- 1M return
- -6.47%
- -
- 1Y return
- -31.65%
- -
- Industry
- Major Chemicals
- Major Chemicals
- Exchange
- NYSE
- NASDAQ
- IPO
- 2017
- 2013
- News (4w)
- 18
- 0
- Recent ratings
- 25
- 2
DuPont de Nemours Inc.
DuPont de Nemours, Inc. provides technology-based materials, ingredients, and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. The company's Electronics & Imaging segment supplies materials to manufacture photovoltaics and solar cells; materials and printing systems to the advanced printing industry; and materials and solutions for the fabrication of semiconductors and integrated circuits addressing front-end and back-end of the manufacturing process. This segment also provides semiconductor and advanced packaging materials; dielectric and metallization solutions for chip packaging; and silicones for light emitting diode packaging and semiconductor applications; permanent and process chemistries for the fabrication of printed circuit boards to include laminates and substrates, electroless, and electrolytic metallization solutions, as well as patterning solutions, and materials and metallization processes for metal finishing, decorative, and industrial applications. In addition, it offers various materials to manufacture rigid and flexible displays for liquid crystal displays, advanced-matrix organic light emitting diode, and quantum dot applications. The Transportation & Advanced Polymers segment provides engineering resins, adhesives, silicones, lubricants, and parts to engineers and designers in the transportation, electronics, healthcare, industrial, and consumer end-markets. Its Safety & Construction segment provides engineered products and integrated systems for worker safety, water purification and separation, aerospace, energy, medical packaging, and building materials. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc. is based in Wilmington, Delaware.
Marrone Bio Innovations Inc.
Marrone Bio Innovations, Inc. discovers, develops, produces, and promotes biological products for pest management, plant nutrition, and plant health in the United States and internationally. Its products include Emergen, Foramin, Foramin ST, Pacesetter, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil borne insects. The company also offers Regalia and Stargus, which are bio fungicides that protects against fungal and bacterial diseases and enhances yields/quality; Venerate, a bioinsecticide, which controls chewing and sucking insects and mites, as well as flies and plant parasitic nematodes; and Zelto, a bionematicide that protects turf, including golf course fairways and greens, and promotes turf health by enhancing plant and root health. The company provides its products directly through sales force, as well as through distributors and other commercial partners. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was incorporated in 2006 and is headquartered in Davis, California.
Latest DD
- CEO Koch Lori covered exercise/tax liability with 4,673 shares and sold $12,741 worth of shares (261 units at $48.82), decreasing direct ownership by 1% to 345,172 units (SEC Form 4)
- SVP & CFO Franzen Antonella B covered exercise/tax liability with 1,558 shares, decreasing direct ownership by 2% to 68,809 units (SEC Form 4)
- Director Macpherson Donald G was granted 671 shares, increasing direct ownership by 13% to 5,868 units (SEC Form 4)
- Director Lowery Frederick M. was granted 800 shares, increasing direct ownership by 2% to 40,205 units (SEC Form 4)
- Director Cutler Alexander M was granted 1,033 shares, increasing direct ownership by 1% to 81,794 units (SEC Form 4)
- SEC Form SD filed by DuPont de Nemours Inc.
- Director Breen Edward D was granted 4,030 shares, increasing direct ownership by 1% to 278,008 units (SEC Form 4)
- Director Macpherson Donald G was granted 4,030 shares, increasing direct ownership by 345% to 5,197 units (SEC Form 4)
- Director Mcmaken Kurt B was granted 4,030 shares, increasing direct ownership by 95% to 8,258 units (SEC Form 4)
- Director Lowery Frederick M. was granted 4,030 shares, increasing direct ownership by 11% to 39,405 units (SEC Form 4)
Latest MBII
- ROTH MKM's Agribusiness Investment Banking Group Sees Success with the Closing of Three M&A Sellside Transactions
- Shares of chemicals companies are trading lower amid economic uncertainty following a bearish outlook from FedEx. An economic slowdown could weigh on end markets for chemicals and materials.
- SEC Form 15-12G filed by Marrone Bio Innovations Inc.
- SEC Form EFFECT filed by Marrone Bio Innovations Inc.
- SEC Form EFFECT filed by Marrone Bio Innovations Inc.
- SEC Form EFFECT filed by Marrone Bio Innovations Inc.
- SEC Form EFFECT filed by Marrone Bio Innovations Inc.
- SEC Form EFFECT filed by Marrone Bio Innovations Inc.
- SEC Form S-8 POS filed by Marrone Bio Innovations Inc.
- SEC Form S-8 POS filed by Marrone Bio Innovations Inc.